BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

857 related articles for article (PubMed ID: 11679937)

  • 21. Discrimination of double primary lung cancer from intrapulmonary metastasis by p53 gene mutation.
    Matsuzoe D; Hideshima T; Ohshima K; Kawahara K; Shirakusa T; Kimura A
    Br J Cancer; 1999 Mar; 79(9-10):1549-52. PubMed ID: 10188905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p53 protein accumulation and gene mutations in multifocal esophageal precancerous lesions from symptom free subjects in a high incidence area for esophageal carcinoma in Henan, China.
    Wang LD; Zhou Q; Hong JY; Qiu SL; Yang CS
    Cancer; 1996 Apr; 77(7):1244-9. PubMed ID: 8608498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rearrangement of p53 gene with overexpressed p53 protein in primary cervical cancer.
    Sahu GR; Nayak BK; Patnaik S; Parija T; Das BR
    Oncol Rep; 2002; 9(2):433-7. PubMed ID: 11836622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p53 mutational spectrum of esophageal carcinomas from five different geographical locales in China.
    Lung ML; Chan WC; Zong YS; Tang CM; Fok CL; Wong KT; Chan LK; Lau KW
    Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):277-84. PubMed ID: 8722219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of p53 mutations in squamous cell carcinoma of the lung. Acquisition at a relatively early age.
    Zheng J; Shu Q; Li ZH; Tsao JI; Weiss LM; Shibata D
    Am J Pathol; 1994 Dec; 145(6):1444-9. PubMed ID: 7992847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p53 mutation and protein accumulation during multistage human esophageal carcinogenesis.
    Bennett WP; Hollstein MC; Metcalf RA; Welsh JA; He A; Zhu SM; Kusters I; Resau JH; Trump BF; Lane DP
    Cancer Res; 1992 Nov; 52(21):6092-7. PubMed ID: 1394236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The role of P53 gene in the development of oral squamous cell carcinoma: study of P53 gene mutation by silver staining polymerase chain reaction-single strand conformation polymorphism].
    Chen Q; Fu J; Yang G
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1996 Nov; 31(6):337-40. PubMed ID: 9592286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53 alterations in plutonium-induced F344 rat lung tumors.
    Kelly G; Stegelmeier BL; Hahn FF
    Radiat Res; 1995 Jun; 142(3):263-9. PubMed ID: 7761575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human papillomavirus infection and p53 alteration in oral squamous cell carcinoma.
    Cao J; Zhang ZY; Patima ; Zhang YX; Chen WT
    Chin J Dent Res; 2000 Nov; 3(3):44-9. PubMed ID: 11314535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum anti-p53 autoantibodies from patients with idiopathic pulmonary fibrosis associated with lung cancer.
    Oshikawa K; Sugiyama Y
    Respir Med; 2000 Nov; 94(11):1085-91. PubMed ID: 11127496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of p53 mutations with metastatic prostate cancer.
    Eastham JA; Stapleton AM; Gousse AE; Timme TL; Yang G; Slawin KM; Wheeler TM; Scardino PT; Thompson TC
    Clin Cancer Res; 1995 Oct; 1(10):1111-8. PubMed ID: 9815901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors.
    Tam AS; Foley JF; Devereux TR; Maronpot RR; Massey TE
    Cancer Res; 1999 Aug; 59(15):3634-40. PubMed ID: 10446974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p53 inactivation in chewing tobacco-induced oral cancers and leukoplakias from India.
    Saranath D; Tandle AT; Teni TR; Dedhia PM; Borges AM; Parikh D; Sanghavi V; Mehta AR
    Oral Oncol; 1999 May; 35(3):242-50. PubMed ID: 10621843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of K-ras and p53 mutations in bronchoscopically obtained malignant and non-malignant tissue from patients with non-small cell lung cancer.
    Lang SM; Stratakis DF; Freudling A; Ebelt K; Oduncu F; Hautmann H; Huber RM
    Eur J Med Res; 2000 Aug; 5(8):341-6. PubMed ID: 10958767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p53 overexpression and human papillomavirus (HPV) infection in oesophageal squamous cell carcinomas derived from a high-incidence area in China.
    Chang F; Syrjänen S; Wang L; Shen Q; Syrjänen K
    Anticancer Res; 1997; 17(1B):709-15. PubMed ID: 9066606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of p53 alterations in patients with non-small cell lung cancer: a meta-analysis.
    Mitsudomi T; Hamajima N; Ogawa M; Takahashi T
    Clin Cancer Res; 2000 Oct; 6(10):4055-63. PubMed ID: 11051256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Analysis of p53 gene mutation in esophageal exfoliative cells].
    Kou YL; Zhang JR; Zhou Q; Zhao YF; Chen GD
    Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):349-52. PubMed ID: 15312345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of p53 mutations in bilateral breast carcinoma.
    Ackerman J; Baunoch DA; Gimotty P; George J; Lane MA; Dawson PJ
    Mod Pathol; 1995 Apr; 8(3):244-8. PubMed ID: 7617647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations of the p53 gene in human lung cancer from chromate-exposed workers.
    Kondo K; Hino N; Sasa M; Kamamura Y; Sakiyama S; Tsuyuguchi M; Hashimoto M; Uyama T; Monden Y
    Biochem Biophys Res Commun; 1997 Oct; 239(1):95-100. PubMed ID: 9345276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutational spectra of p53 in geographically localized esophageal squamous cell carcinoma groups in China.
    Cao W; Chen X; Dai H; Wang H; Shen B; Chu D; McAfee T; Zhang ZF
    Cancer; 2004 Aug; 101(4):834-44. PubMed ID: 15305417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.